Navneet Majhail, MD, Hematology, Cleveland, OH, Cleveland Clinic

NavneetSinghMajhailMDMS

Hematology Cleveland, OH

Hematologic Oncology

Director, Blood & Marrow Transplant Program, Cleveland Clinic; Professor of Medicine, Cleveland Clinic Lerner College of Medicine; President (2019), American Society for Transplantation and Cellular Therapy

Overview of Dr. Majhail

Dr. Navneet Majhail is a hematologist in Cleveland, OH and is affiliated with Cleveland Clinic. He received his medical degree from Government Medical College Chandigrah and has been in practice 20 years. He is one of 21 doctors at Cleveland Clinic who specialize in Hematology.

Education & Training

  • University of Minnesota
    University of MinnesotaFELLOWSHIP
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationRESIDENCY
  • Government Medical College Chandigrah
    Government Medical College ChandigrahMEDICAL_SCHOOL

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2016 - 2020
  • MN State Medical License
    MN State Medical License 2006 - 2014
  • OH State Medical License
    OH State Medical License 2000 - 2022
  • American Board of Internal Medicine Hematology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Inotuzumab Ozogamicin Post-Transplant for Acute Lymphocytic Leukemia
    Navneet S. Majhail, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Pattern of Somatic Mutation Changes from Diagnosis to Relapse Following Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Acute Myeloid Leukemia (AML) and My...
    Navneet S. Majhail, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Targeted Treatment and Survival Following Relapse after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia and MDS in the Contemporary Era
    Navneet S. Majhail, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • How to Set up a Health Services and Outcomes Research Program 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Impact of Clinical Versus Biochemical Progression on Post-Progression Survival in Multiple Myeloma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Access and Referral Barriers to Autologous and Allogeneic Hematopoietic Cell Transplantation in Adult Patients with Cancer: A Systematic Review with a Specific Focus o... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Professional Memberships

Hospital Affiliations